Volume 24, Number 9—September 2018
Research Letter
Spread of mcr-1–Driven Colistin Resistance on Hospital Surfaces, Italy
Table
Bacteria |
No. isolates |
Drug-resistant isolates, % (MIC, mg/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
F |
AK |
ATM |
TZP |
C |
SXT |
NET |
CTX |
Col-R |
||
Acinetobacter Iwoffii | 4 | 50 | 25 | 50 | 50 | 25 | 50 | 25 | 25 | 7 (4–8) |
Citrobacter freundii | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 4 |
Enterobacter cloacae | 3 | 100 | 100 | 33.3 | 100 | 33.3 | 33.3 | 100 | 33.3 | 16 |
Enterobacter agglomerans | 3 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 5.3 (4–8) |
Escherichia coli | 4 | 100 | 50 | 25 | 100 | 0 | 25 | 100 | 50 | 10 (8–16) |
Klebsiella pneumoniae | 6 | 100 | 100 | 33.3 | 66.6 | 66.6 | 0 | 100 | 66.6 | 13.3 (8–16) |
K. oxytoca | 2 | 100 | 100 | 0 | 0 | 0 | 0 | 100 | 0 | 16 |
Pseudomonas aeruginosa | 1 | 0 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 4 |
P. putida | 1 | 0 | 100 | 0 | 0 | 100 | 0 | 100 | 0 | 8 |
*AK, amikacin 30 μg; ATM, aztreonam 30 μg; C, chloramphenicol 30 μg; Col-R, colistin resistant; CTX, cefotaxime 5 μg; F, nitrofurantoin 100 μg; NET, netilmicin 10 μg; SXT, trimethoprim/sulfamethoxazole 25 μg; TZP, piperacillin/tazobactam 36 μg.
Page created: August 16, 2018
Page updated: August 16, 2018
Page reviewed: August 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.